Thompson Siegel & Walmsley LLC Acquires 56,499 Shares of Herbalife Ltd. (NYSE:HLF)

Thompson Siegel & Walmsley LLC raised its stake in shares of Herbalife Ltd. (NYSE:HLF) by 13.1% during the 3rd quarter, Holdings Channel.com reports. The fund owned 486,409 shares of the company’s stock after purchasing an additional 56,499 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in Herbalife were worth $3,497,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. Baupost Group LLC MA grew its position in Herbalife by 128.3% in the 2nd quarter. Baupost Group LLC MA now owns 5,124,526 shares of the company’s stock worth $53,244,000 after purchasing an additional 2,879,603 shares during the period. Marshall Wace LLP boosted its position in Herbalife by 2,053.6% in the second quarter. Marshall Wace LLP now owns 1,977,155 shares of the company’s stock worth $20,543,000 after purchasing an additional 1,885,346 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its stake in shares of Herbalife by 3,832.5% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 1,157,309 shares of the company’s stock valued at $11,631,000 after purchasing an additional 1,127,880 shares during the period. Renaissance Technologies LLC increased its position in shares of Herbalife by 11.6% during the 2nd quarter. Renaissance Technologies LLC now owns 6,653,401 shares of the company’s stock valued at $69,129,000 after purchasing an additional 692,800 shares during the last quarter. Finally, Iridian Asset Management LLC CT lifted its stake in shares of Herbalife by 43.7% in the 3rd quarter. Iridian Asset Management LLC CT now owns 2,228,193 shares of the company’s stock worth $16,021,000 after purchasing an additional 677,739 shares during the period.

Herbalife Trading Up 1.1 %

Shares of NYSE:HLF opened at $8.50 on Friday. The company has a market cap of $856.72 million, a price-to-earnings ratio of 9.90, a PEG ratio of 0.27 and a beta of 1.17. The company has a 50-day moving average price of $7.38 and a 200 day moving average price of $9.23. Herbalife Ltd. has a 12 month low of $6.59 and a 12 month high of $15.66.

Herbalife (NYSE:HLF) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.38. Herbalife had a net margin of 1.73% and a negative return on equity of 18.66%. The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.23 billion. As a group, equities analysts forecast that Herbalife Ltd. will post 1.51 EPS for the current year.

Insider Activity

In related news, Director Juan Miguel Mendoza bought 10,000 shares of Herbalife stock in a transaction dated Monday, August 26th. The shares were acquired at an average cost of $8.72 per share, with a total value of $87,200.00. Following the completion of the transaction, the director now owns 110,000 shares in the company, valued at $959,200. The trade was a 10.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Over the last 90 days, insiders have acquired 25,000 shares of company stock valued at $199,475. 0.94% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on HLF shares. Citigroup cut their target price on shares of Herbalife from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Friday, October 25th. DA Davidson decreased their price objective on shares of Herbalife from $13.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, October 31st. Mizuho upped their target price on shares of Herbalife from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Friday, November 1st. StockNews.com raised Herbalife from a “hold” rating to a “buy” rating in a report on Monday, November 4th. Finally, B. Riley dropped their price objective on Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Herbalife currently has an average rating of “Hold” and a consensus price target of $9.90.

Herbalife Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.